According to Gram Research analysis, intermittent fasting reduces HbA1c by 0.3-1.2% in adults with type 2 diabetes and works about as well as traditional calorie restriction for improving blood sugar control. A 2026 review of nearly 40 clinical trials found that different fasting approaches—including time-restricted eating and the 5:2 diet—help lower blood sugar and support weight loss without increasing dangerous low blood sugar episodes when medications are properly adjusted. However, intermittent fasting is not yet an official recommendation in diabetes guidelines.
A major review in The Lancet Diabetes & Endocrinology examines whether intermittent fasting—eating within specific time windows or on certain days—can help people with diabetes. After analyzing nearly 40 clinical trials, researchers found that intermittent fasting works about as well as regular calorie restriction for improving blood sugar control in adults with type 2 diabetes. The study shows that different fasting approaches, like eating only during an 8-hour window or the 5:2 diet, can lower HbA1c (a key diabetes marker) by 0.3-1.2% and help with weight loss. However, experts say more research is needed before adding intermittent fasting to official diabetes treatment guidelines.
Key Statistics
A 2026 review in The Lancet Diabetes & Endocrinology analyzing nearly 40 clinical trials found that intermittent fasting reduced HbA1c by 0.3-1.2% in adults with type 2 diabetes, matching the effectiveness of traditional calorie restriction.
According to research reviewed by Gram, intermittent fasting did not increase the risk of hypoglycemia (dangerously low blood sugar) in people with type 2 diabetes when medications were adjusted using simple clinical rules.
A comprehensive analysis of over 225 clinical trials found that intermittent fasting is now the third most commonly practiced diet in the USA, yet it has not been included in official American Diabetes Association or International Diabetes Federation clinical practice guidelines.
Research shows that multiple types of intermittent fasting—including time-restricted eating, the 5:2 diet, and fasting-mimicking diets—all produced similar improvements in blood sugar control and weight loss in adults with type 2 diabetes.
The Quick Take
- What they studied: Whether intermittent fasting (eating during limited time periods) can help people with type 2 diabetes control their blood sugar levels
- Who participated: Analysis of nearly 40 clinical trials involving adults with type 2 diabetes, prediabetes, type 1 diabetes, and gestational diabetes
- Key finding: In adults with type 2 diabetes, intermittent fasting lowered HbA1c (a blood sugar marker) by 0.3-1.2% and worked about as well as traditional calorie restriction, without increasing dangerous low blood sugar episodes when medications were properly adjusted
- What it means for you: If you have type 2 diabetes, intermittent fasting might be a helpful option to discuss with your doctor, though it’s not yet an official recommendation. It appears to work similarly to other proven methods, but you’ll need medical supervision to adjust medications safely
The Research Details
This was a comprehensive review article published in The Lancet Diabetes & Endocrinology that examined evidence from more than 225 clinical trials about intermittent fasting. The authors focused specifically on nearly 40 trials involving people with diabetes or prediabetes. They looked at different types of intermittent fasting, including time-restricted eating (eating only during certain hours), the 5:2 diet (eating normally five days, restricting calories two days), and fasting-mimicking diets (eating very few calories on certain days).
The researchers compared how well intermittent fasting worked compared to regular eating patterns and traditional calorie restriction. They examined effects on HbA1c (a measure of average blood sugar over three months), fasting blood glucose, 24-hour glucose patterns, body weight, and the risk of hypoglycemia (dangerously low blood sugar). They also reviewed safety data and looked at whether the approach worked differently for different types of diabetes.
This type of review is valuable because it synthesizes findings from many individual studies to identify patterns and draw broader conclusions about whether a treatment approach is ready for real-world use in clinical practice.
This research approach matters because intermittent fasting is already very popular—it’s the third most commonly practiced diet in the USA—yet official medical guidelines haven’t officially recommended it for diabetes treatment. By reviewing all available clinical trial evidence together, the authors could determine whether the scientific evidence is strong enough to justify updating official guidelines. This helps doctors know what’s safe and effective to recommend to their patients.
This review was published in The Lancet Diabetes & Endocrinology, one of the world’s most respected medical journals. The authors examined nearly 40 clinical trials, which provides a substantial evidence base. However, this is a ‘Personal View’ article rather than a formal systematic review with predetermined criteria, which means it involved some expert judgment in selecting and interpreting studies. The strength of evidence varies across different types of diabetes—stronger for type 2 diabetes, weaker for type 1 and gestational diabetes.
What the Results Show
In adults with type 2 diabetes, intermittent fasting consistently improved blood sugar control. The most commonly measured improvement was in HbA1c, which typically decreased by 0.3-1.2% compared to people who ate normally. This improvement is meaningful because even small reductions in HbA1c are associated with better long-term health outcomes.
Importantly, intermittent fasting worked about as well as traditional calorie restriction—the standard approach doctors have recommended for decades. Both approaches helped people lose weight and improved their blood sugar control similarly. The research also found that intermittent fasting did not increase the risk of hypoglycemia (dangerously low blood sugar) when people’s diabetes medications were adjusted using straightforward rules.
The review examined several different types of intermittent fasting and found that multiple approaches appeared effective, including time-restricted eating (like eating only between noon and 8 PM), the 5:2 diet, and fasting-mimicking diets. This suggests that people might have options to choose an approach that fits their lifestyle.
Beyond blood sugar control, intermittent fasting also contributed to weight loss, which is important because excess weight makes diabetes harder to manage. The research suggests intermittent fasting might also help people with prediabetes (higher-than-normal blood sugar that hasn’t yet become diabetes) prevent or delay developing type 2 diabetes, though the evidence is less robust for this group.
The review found insufficient evidence to recommend intermittent fasting for people with type 1 diabetes or gestational diabetes (diabetes during pregnancy). This is an important distinction because type 1 diabetes involves different biology and requires insulin therapy, which makes fasting more complicated and potentially risky without careful medical supervision.
This review builds on growing evidence over the past decade suggesting that intermittent fasting might be beneficial for metabolic health. Previous research has shown that intermittent fasting can improve insulin sensitivity and reduce inflammation. What’s new here is the comprehensive synthesis showing that intermittent fasting works about as well as calorie restriction—the gold standard approach—for type 2 diabetes specifically. This is significant because it suggests intermittent fasting deserves consideration as an official treatment option rather than just an alternative diet trend.
The review acknowledges several important limitations. First, while there are nearly 40 trials in people with diabetes, many are relatively small and short-term. Longer studies would help confirm that benefits persist over years. Second, the quality and design of individual trials varies, which can affect how confident we should be in the results. Third, most research has focused on type 2 diabetes; there’s much less evidence for other types. Fourth, the review doesn’t deeply examine which types of people might benefit most or whether certain fasting approaches work better for specific individuals. Finally, this is a ‘Personal View’ rather than a formal systematic review, meaning the authors used some judgment in selecting studies rather than following predetermined criteria.
The Bottom Line
For adults with type 2 diabetes: Intermittent fasting appears to be a reasonable option to discuss with your doctor as one of several evidence-based lifestyle approaches. It may help improve blood sugar control and support weight loss similarly to traditional calorie restriction. Confidence level: Moderate to High for type 2 diabetes. For people with prediabetes: Intermittent fasting might help prevent or delay type 2 diabetes, but discuss this with your healthcare provider. Confidence level: Moderate. For type 1 diabetes or gestational diabetes: There isn’t enough evidence yet to recommend intermittent fasting without close medical supervision. Confidence level: Low.
Adults with type 2 diabetes or prediabetes who are interested in lifestyle approaches to improve their blood sugar control should discuss intermittent fasting with their doctor. People already doing intermittent fasting who have diabetes should ensure their doctor knows and can adjust medications appropriately. Healthcare providers should consider intermittent fasting as one option to offer patients. People with type 1 diabetes, gestational diabetes, or those taking certain medications should consult their doctor before attempting intermittent fasting.
Based on the research reviewed, improvements in blood sugar control typically appear within weeks to a few months of starting intermittent fasting. Weight loss often follows a similar timeline. However, the most significant benefits for long-term diabetes management would likely develop over several months of consistent practice. It’s important to work with your healthcare team throughout this process, as medication adjustments may be needed.
Frequently Asked Questions
Does intermittent fasting actually help with diabetes control?
Yes, research shows intermittent fasting reduces HbA1c by 0.3-1.2% in type 2 diabetes, matching traditional calorie restriction. It also helps with weight loss and doesn’t increase dangerous low blood sugar when medications are adjusted properly with doctor supervision.
Is intermittent fasting safe for people taking diabetes medications?
Intermittent fasting can be safe with proper medical supervision and medication adjustment using established clinical rules. However, you must work closely with your doctor to monitor blood sugar and adjust medications as needed to prevent dangerously low levels.
What types of intermittent fasting work best for diabetes?
Research shows multiple approaches work similarly: time-restricted eating (eating during specific hours), the 5:2 diet (eating normally five days, restricting calories two days), and fasting-mimicking diets all improved blood sugar control. Choose whichever fits your lifestyle best.
Can people with type 1 diabetes use intermittent fasting?
There isn’t enough research evidence yet to recommend intermittent fasting for type 1 diabetes. Type 1 requires insulin therapy, making fasting more complicated. Discuss this only with your endocrinologist if you’re interested.
How long does it take to see improvements from intermittent fasting?
Blood sugar improvements typically appear within weeks to a few months of starting intermittent fasting. Weight loss often follows a similar timeline. Long-term benefits develop over several months of consistent practice with medical supervision.
Want to Apply This Research?
- Track your fasting windows daily (e.g., ‘Fasted 12-8 PM’) and log your blood sugar readings at the same times each week to see patterns. Record your weight weekly and note any changes in how you feel (energy levels, hunger, mood).
- Start with a modest fasting window (like 12 hours overnight) and gradually extend it as comfortable. Use the app to set reminders for your eating window, log meals during eating periods, and track blood sugar before and after fasting days. Share weekly summaries with your healthcare provider.
- Weekly: Review fasting consistency and blood sugar patterns. Monthly: Check weight trends and HbA1c if available. Quarterly: Discuss results with your doctor to determine if medication adjustments are needed. Maintain a log of any low blood sugar episodes or concerning symptoms to share with your healthcare team.
This article summarizes research findings and should not replace professional medical advice. Intermittent fasting can affect diabetes medications and blood sugar levels. Before starting intermittent fasting, consult your doctor or endocrinologist, especially if you take diabetes medications, insulin, or have other health conditions. Do not adjust medications without medical supervision. People with type 1 diabetes, gestational diabetes, a history of eating disorders, or those pregnant or breastfeeding should seek medical guidance before attempting intermittent fasting. This review is current as of June 2026 and represents expert interpretation of available evidence at that time.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.